HRT and GLP-1: What Women Need to Know About Combining These Therapies At a glance Primary GLP-1 agents used with HRT / semaglutide 2.4 mg (Wegovy) and tirzepatide 15 mg (Zepbound) Mean weight loss with semaglutide 2.4 mg / 14.9% at 68 weeks in STEP-1 (N=1,961) Estrogen effect on visceral fat / transdermal 17-beta-estradiol reduces visceral adiposity by ~6-7% vs placebo per RCT data Oral estrogen risk with GLP-1 / slowed gastric emptying may reduce absorption
Potential therapeutic interventions to balance opposing but interconnected cell damage and survival pathways, such as antioxidants, anti-apoptotics, and pro-inflammatory cytokine inhibitors, are also discussed
Match workouts with sufficient protein timing to aid repair
Our team at En Vogue IV Therapy & Wellness works closely with clients to evaluate their health, body composition, and weight loss goals
Once the peptide is no longer present in the body, the stimulation of pigment-producing cells reduces and, over time, normal skin turnover gradually diminishes the excess pigmentation, Dr
The degree of expression of the effects of various cellular pathways is mediated by the structure, functions of individual co-chaperones and their interaction with HSP70
